A new report titled “Monoclonal Antibodies in Veterinary Health Market – Forecast to 2032” by Eternal Market, the global monoclonal antibodies in veterinary health industry is projected to grow at a compound annual growth rate (CAGR) of 13.7% from 2023 to 2032, reaching a value of USD 3,527.4 million by the end of the forecast period.
Global monoclonal antibodies in veterinary health industry outlook
Monoclonal antibodies (mAbs) within the veterinary health market are specialized molecules meticulously crafted in laboratories to target specific substances within animals. These antibodies have diverse applications, aiding veterinarians in disease identification and offering precise therapies for conditions such as infections, autoimmune disorders, and specific cancers. End users of these mAbs encompass veterinary clinics, animal owners, research institutions, and animal health companies, collectively contributing to the enhancement of veterinary care and the progression of animal health outcomes.
Monoclonal antibodies have assumed pivotal roles in the veterinary realm, functioning as both diagnostic tools and therapeutic interventions. By accurately identifying and binding to specific antigens in animals, these engineered molecules facilitate precise disease diagnosis and enable tailored treatment approaches. With applications spanning veterinary clinics, research laboratories, farms, and households, monoclonal antibodies make substantial contributions to elevating animal well-being and advancing the field of veterinary medicine.
Key Visions
- Estimated CAGR of around 13.7% over the forecast period (2023-2032).
- Global monoclonal antibodies in veterinary health Industry size is projected to reach USD 3,527.4 million by 2032 from USD 698.3 million in 2022.
- Increasing awareness of zoonotic diseases is the key market driver.
- By product type segmentation, in 2022, therapeutic monoclonal antibodies was estimated to hold largest market share.
- By animal type segmentation, in 2022, companion animals was the largest revenue contributor.
- By end users, veterinary clinics and hospitals segment to hold dominant position in 2023.
- North America to lead the market in 2023
Global monoclonal antibodies in veterinary health industry forces
Increasing awareness of zoonotic diseases has been a significant driver for the global monoclonal antibodies in veterinary health market.
The emergence of zoonotic diseases has significantly impacted both human and animal health on a global scale. Zoonotic diseases are those that can be transmitted between animals and humans, posing a unique and complex challenge due to their ability to cross species barriers. This phenomenon often stems from the close interaction between humans, domestic animals, and wildlife, which provides opportunities for pathogens to jump between species.
Zoonotic diseases can have far-reaching consequences, affecting public health, agriculture, economies, and ecosystems. The COVID-19 pandemic, caused by the zoonotic SARS-CoV-2 virus, highlighted the rapid spread and devastating impact of such diseases. Effective management of zoonotic diseases requires a One Health approach, recognizing the interconnectedness of human, animal, and environmental health. Monitoring and early detection of potential zoonotic threats, along with promoting responsible practices in animal husbandry, wildlife conservation, and public health, are vital to mitigating the risks posed by these diseases.
In the veterinary context, the emergence of zoonotic diseases underscores the importance of proactive disease surveillance, vaccination, and effective treatment strategies. Monoclonal antibodies have gained attention as a potential tool for both preventing and treating zoonotic infections in animals, limiting their spread to humans. By addressing zoonosis at the animal source, these antibodies can contribute to reducing the risk of transmission to humans and minimizing the impact of outbreaks. Thus, the emergence of zoonotic diseases emphasizes the critical need for collaboration between veterinary and human health sectors to ensure a holistic and coordinated response to these complex global health challenges.
Shift towards personalized medicine has been a significant driver for the global monoclonal antibodies in veterinary health market
The shift toward personalized medicine represents a transformative approach in healthcare, tailoring medical interventions to individual characteristics, needs, and genetic profiles. This paradigm recognizes that each patient’s response to treatment can vary due to genetic, environmental, and lifestyle factors. Personalized medicine aims to optimize therapeutic outcomes while minimizing adverse effects by providing targeted treatments that match a patient’s specific biological makeup.
In the context of personalized veterinary medicine, this approach is gaining momentum as advancements in genomics and diagnostics enable a deeper understanding of animals’ genetic predispositions to diseases. Veterinarians can now identify genetic markers that influence an animal’s response to various treatments, allowing for more precise and effective therapies. Monoclonal antibodies play a pivotal role in personalized veterinary medicine, as their specificity and customizable nature align well with tailoring treatments to individual animals. By offering treatments that are better aligned with an animal’s unique biological characteristics, personalized medicine is not only enhancing the quality of veterinary care but also contributing to the overall well-being of animals across diverse species.
Global monoclonal antibodies in veterinary health industry trends
Development of new mAbs for a wider range of diseases: Researchers are developing new mAbs for a wider range of diseases in animals, including cancer, infectious diseases, and autoimmune diseases. This is making it possible to treat more animals with more effective and targeted therapies.
Improved delivery methods for mAbs: Researchers are developing new ways to deliver mAbs to animals, such as through oral formulations and transdermal patches. This is making it easier and more convenient to administer mAbs to animals.
Increased use of mAbs in combination therapies: mAbs are increasingly being used in combination with other therapies, such as chemotherapy and antibiotics. This is leading to more effective and durable responses in animals with cancer and other diseases.
Growing adoption of mAbs in veterinary telemedicine: mAbs are being used more frequently in veterinary telemedicine consultations. This is making it possible for veterinarians to provide care to animals remotely, which can be more convenient and affordable for pet owners.
Global monoclonal antibodies in veterinary health industry segments
The global monoclonal antibodies in veterinary health market is segmented By Product Type (Therapeutic Monoclonal Antibodies, Diagnostic Monoclonal Antibodies, and Combination Products), By Animal Type (Companion Animals (Dogs, Cats, and Horses), Livestock (Cattle, Pigs, and Poultry), and Exotic Animals) By End User (Veterinary Clinics and Hospitals, Animal Owners, Livestock Producers, Research Institutions, Pharmaceutical Companies).
Based on product type, the therapeutic monoclonal antibodies segment is expected to grow at the high rate during the forecast period. In 2022, the segment contributed around 33.1% of the overall market and expected to hold a share of 35.5% by 2031.
Therapeutic monoclonal antibodies are actively used to treat various medical conditions in animals, including cancer, autoimmune diseases, and infectious diseases. These antibodies are designed to target specific antigens or cells involved in the disease process, offering precise and often highly effective treatments.
Based on animal type, in 2022, the companion animals segment is expected to hold large share of 59.3% in the market. Companion animals, including dogs, cats, and horses, often lead in terms of market share and revenue within the veterinary health market. This is due to the strong emotional bond between pet owners and their companion animals, driving higher demand for advanced healthcare and treatments.
Based on end user, the veterinary clinics and hospitals segment is expected to grow with the CAGR of 11.5% during the forecast period. These facilities serve as the frontline for animal care and treatment, making them a central hub for adopting and administering various veterinary therapies, including monoclonal antibodies.
Global monoclonal antibodies in veterinary health industry competitors
Key players operating in the global monoclonal antibodies in veterinary health market include Zoetis, Elanco, Boehringer Ingelheim Animal Health, Merck Animal Health, Abaxis (now part of Zoetis), Virbac, IDEXX Laboratories, Bayer Animal Health, Ceva Animal Health, and Heska Corporation among others.
Industry Developments:
In 2022, Zoetis launched its first monoclonal antibody for veterinary use, ZyrTEC-V, in the United States in 2022. ZyrTEC-V is a treatment for allergic dermatitis in dogs.
In 2022, Elanco Animal Health acquired Anivive Lifesciences in 2022. Anivive is a company that develops monoclonal antibodies for veterinary use. The acquisition will give Elanco a portfolio of monoclonal antibodies for the treatment of cancer, pain, and other diseases in animals.
In 2022, Boehringer Ingelheim launched its first monoclonal antibody for veterinary use, Palladia, in the European Union in 2023. Palladia is a treatment for bladder cancer in dogs.
Major Strategies adopted by key market players
- Agreements, Collaborations, and Partnerships: 32.9%
- Acquisitions: 26%
- New Product Launch: 21%
- Other Developments: 20.1%
Scope of the Report:
Global Monoclonal Antibodies in Veterinary Health Market, by Product Type
- Therapeutic monoclonal antibodies
- Diagnostic monoclonal antibodies
- Combination products
Global Monoclonal Antibodies in Veterinary Health Market, By Animal Type:
- Companion animals (dogs, cats, horses),
- Livestock (cattle, pigs, poultry)
- Exotic animals
Global Monoclonal Antibodies in Veterinary Health Market, By End user:
- Veterinary clinics and hospitals
- Animal owners
- Livestock producers
- Research institutions
- Pharmaceutical companies
Global Monoclonal Antibodies in Veterinary Health Market, By Region
- North America
- Europe
- Germany
- U.K
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- China
- Japan
- India
- Rest of APAC (RoAPAC)
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of MEA
Companies Profiled
- Zoetis
- Elanco
- Boehringer Ingelheim Animal Health
- Merck Animal Health
- Abaxis (now part of Zoetis)
- Virbac
- IDEXX Laboratories
- Bayer Animal Health
- Ceva Animal Health
- Heska
- Other Players
*The report scope shall be customized as per the requirements
Chapter 1 Global Monoclonal Antibodies in Veterinary Health Market Overview
1.1 Introduction
1.2 Drivers for Monoclonal Antibodies in Veterinary Health Market
1.3 Restraints for Monoclonal Antibodies in Veterinary Health Market
1.4 Opportunities for Monoclonal Antibodies in Veterinary Health Market
1.5 Trends for Monoclonal Antibodies in Veterinary Health Market
1.6 Macro-economic Factors
1.7 Regulatory Framework
1.8 Opportunity Map Analysis
1.9 Opportunity Orbits
1.10 Market Investment Feasibility Index
1.11 PEST Analysis
1.12 PORTER’S Five Force Analysis
1.13 Go to Market Strategy
1.14 Marketing Strategy
1.15 Technology Roadmap
1.16 Advances in product/services adoption worldwide
1.17 Regional Market Share and BPS Analysis
Chapter 2 Global Monoclonal Antibodies in Veterinary Health Market Competitive Analysis
2.1 Market Competition Scenario Analysis, By Company
2.2 Competitor Landscape
2.3 Major Strategies adopted by key market players (2020-2022)
2.4 Recent Developments/Investments/Announcements
2.5 Company Profiles
2.5.1 Zoetis
2.5.1.1 Company Overview
2.5.1.2 Business Description
2.5.1.3 Product Portfolio
2.5.1.4 Key Financials
2.5.1.5 Company Presence & Business Segment Analysis – 2022
2.5.1.6 Key Developments
2.5.1.7 SWOT Analysis
2.5.2 Elanco
2.5.2.1 Company Overview
2.5.2.2 Business Description
2.5.2.3 Product Portfolio
2.5.2.4 Key Financials
2.5.2.5 Company Presence & Business Segment Analysis – 2022
2.5.2.6 Key Developments
2.5.2.7 SWOT Analysis
2.5.3 Boehringer Ingelheim Animal Health
2.5.3.1 Company Overview
2.5.3.2 Business Description
2.5.3.3 Product Portfolio
2.5.3.4 Key Financials
2.5.3.5 Company Presence & Business Segment Analysis – 2022
2.5.3.6 Key Developments
2.5.3.7 SWOT Analysis
2.5.4 Merck Animal Health
2.5.4.1 Company Overview
2.5.4.2 Business Description
2.5.4.3 Product Portfolio
2.5.4.4 Key Financials
2.5.4.5 Company Presence & Business Segment Analysis – 2022
2.5.4.6 Key Developments
2.5.4.7 SWOT Analysis
2.5.5 Abaxis (now part of Zoetis)
2.5.5.1 Company Overview
2.5.5.2 Business Description
2.5.5.3 Product Portfolio
2.5.5.4 Key Financials
2.5.5.5 Company Presence & Business Segment Analysis – 2022
2.5.5.6 Key Developments
2.5.5.7 SWOT Analysis
2.5.6 Virbac
2.5.6.1 Company Overview
2.5.6.2 Business Description
2.5.6.3 Product Portfolio
2.5.6.4 Key Financials
2.5.6.5 Company Presence & Business Segment Analysis – 2022
2.5.6.6 Key Developments
2.5.6.7 SWOT Analysis
2.5.7 IDEXX Laboratories
2.5.7.1 Company Overview
2.5.7.2 Business Description
2.5.7.3 Product Portfolio
2.5.7.4 Key Financials
2.5.7.5 Company Presence & Business Segment Analysis – 2022
2.5.7.6 Key Developments
2.5.7.7 SWOT Analysis
2.5.8 Bayer Animal Health
2.5.8.1 Company Overview
2.5.8.2 Business Description
2.5.8.3 Product Portfolio
2.5.8.4 Key Financials
2.5.8.5 Company Presence & Business Segment Analysis – 2022
2.5.8.6 Key Developments
2.5.8.7 SWOT Analysis
2.5.9 Ceva Animal Health
2.5.9.1 Company Overview
2.5.9.2 Business Description
2.5.9.3 Product Portfolio
2.5.9.4 Key Financials
2.5.9.5 Company Presence & Business Segment Analysis – 2022
2.5.9.6 Key Developments
2.5.9.7 SWOT Analysis
2.5.10 Heska
2.5.10.1 Company Overview
2.5.10.2 Business Description
2.5.10.3 Product Portfolio
2.5.10.4 Key Financials
2.5.10.5 Company Presence & Business Segment Analysis – 2022
2.5.10.6 Key Developments
2.5.10.7 SWOT Analysis
Chapter 3 Global Monoclonal Antibodies in Veterinary Health Market Overview
3.1 Global Monoclonal Antibodies in Veterinary Health Market Outlook (2017-2032)
3.1.1 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2017-2023)
3.1.2 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2024-2032)
3.2 Global Monoclonal Antibodies in Veterinary Health Market by Region
3.2.1 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
3.2.2 Global Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
3.3 Global Monoclonal Antibodies in Veterinary Health Market by Product Type
3.3.1 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
3.3.2 Global Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Product Type, 2023–2032
3.3.3 Global Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
3.4 Global Monoclonal Antibodies in Veterinary Health Market by Animal Type
3.4.1 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2032)
3.4.2 Global Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Animal Type, 2023–2032
3.5 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Region
3.5.1 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
3.5.2 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
3.6 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
3.6.2 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
3.7 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Animal Type
3.7.1 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2023)
3.7.2 Global Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2024-2032)
3.8 Global Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate Comparison 2018–2032
3.8.1 Global Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Region
3.8.2 Global Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Product Type
3.8.3 Global Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Animal Type
3.9 Global Monoclonal Antibodies in Veterinary Health Market Share Comparison 2017–2032
3.9.1 Global Monoclonal Antibodies in Veterinary Health Market Share by Region
3.9.2 Global Monoclonal Antibodies in Veterinary Health Market Share by Product Type
3.9.3 Global Monoclonal Antibodies in Veterinary Health Market Share by Animal Type
Chapter 4 North America Monoclonal Antibodies in Veterinary Health Market Overview
4.1 North America Market Snapshot
4.1.1 Regional Overview
4.1.1.1 US
4.1.1.2 Canada
4.1.1.3 Mexico
4.2 North America Monoclonal Antibodies in Veterinary Health Market Outlook (2017-2032)
4.2.1 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2017-2023)
4.2.2 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2024-2032)
4.3 North America Monoclonal Antibodies in Veterinary Health Market by Region
4.3.1 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
4.3.2 North America Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
4.4 North America Monoclonal Antibodies in Veterinary Health Market by Product Type
4.4.1 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
4.4.2 North America Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Product Type, 2023–2032
4.4.3 North America Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
4.5 North America Monoclonal Antibodies in Veterinary Health Market by Animal Type
4.5.1 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2032)
4.5.2 North America Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Animal Type, 2023–2032
4.6 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Region
4.6.1 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
4.6.2 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
4.7 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Product Type
4.7.1 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
4.7.2 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
4.8 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Animal Type
4.8.1 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2023)
4.8.2 North America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2024-2032)
4.9 North America Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate Comparison 2018–2032
4.9.1 North America Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Region
4.9.2 North America Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Product Type
4.9.3 North America Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Animal Type
4.1 North America Monoclonal Antibodies in Veterinary Health Market Share Comparison 2017–2032
4.10.1 North America Monoclonal Antibodies in Veterinary Health Market Share by Region
4.10.2 North America Monoclonal Antibodies in Veterinary Health Market Share by Product Type
4.10.3 North America Monoclonal Antibodies in Veterinary Health Market Share by Animal Type
Chapter 5 Europe Monoclonal Antibodies in Veterinary Health Market Overview
5.1 Europe Market Snapshot
5.1.1 Regional Overview
5.1.1.1 Germany
5.1.1.2 United Kingdom
5.1.1.3 France
5.1.1.4 Italy
5.1.1.5 Spain
5.1.1.6 Russia
5.1.1.7 Rest of Europe
5.2 Europe Monoclonal Antibodies in Veterinary Health Market Outlook (2017-2032)
5.2.1 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2017-2023)
5.2.2 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2024-2032)
5.3 Europe Monoclonal Antibodies in Veterinary Health Market by Region
5.3.1 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
5.3.2 Europe Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
5.4 Europe Monoclonal Antibodies in Veterinary Health Market by Product Type
5.4.1 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
5.4.2 Europe Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Product Type, 2023–2032
5.4.3 Europe Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
5.5 Europe Monoclonal Antibodies in Veterinary Health Market by Animal Type
5.5.1 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2032)
5.5.2 Europe Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Animal Type, 2023–2032
5.6 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Region
5.6.1 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
5.6.2 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
5.7 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Product Type
5.7.1 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
5.7.2 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
5.8 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Animal Type
5.8.1 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2023)
5.8.2 Europe Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2024-2032)
5.9 Europe Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate Comparison 2018–2032
5.9.1 Europe Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Region
5.9.2 Europe Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Product Type
5.9.3 Europe Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Animal Type
5.1 Europe Monoclonal Antibodies in Veterinary Health Market Share Comparison 2017–2032
5.10.1 Europe Monoclonal Antibodies in Veterinary Health Market Share by Region
5.10.2 Europe Monoclonal Antibodies in Veterinary Health Market Share by Product Type
5.10.3 Europe Monoclonal Antibodies in Veterinary Health Market Share by Animal Type
Chapter 6 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Overview
6.1 Asia Pacific Market Snapshot
6.1.1 Regional Overview
6.1.1.1 China
6.1.1.2 India
6.1.1.3 Japan
6.1.1.4 Australia
6.1.1.5 Rest of Asia Pacific
6.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Outlook (2017-2032)
6.2.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2017-2023)
6.2.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2024-2032)
6.3 Asia Pacific Monoclonal Antibodies in Veterinary Health Market by Region
6.3.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
6.3.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
6.4 Asia Pacific Monoclonal Antibodies in Veterinary Health Market by Product Type
6.4.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
6.4.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Product Type, 2023–2032
6.4.3 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
6.5 Asia Pacific Monoclonal Antibodies in Veterinary Health Market by Animal Type
6.5.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2032)
6.5.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Animal Type, 2023–2032
6.6 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Region
6.6.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
6.6.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
6.7 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Product Type
6.7.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
6.7.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
6.8 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Animal Type
6.8.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2023)
6.8.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2024-2032)
6.9 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate Comparison 2018–2032
6.9.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Region
6.9.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Product Type
6.9.3 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Animal Type
6.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Share Comparison 2017–2032
6.10.1 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Share by Region
6.10.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Share by Product Type
6.10.3 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Share by Animal Type
Chapter 7 South America Monoclonal Antibodies in Veterinary Health Market Overview
7.1 South America Market Snapshot
7.1.1 Regional Overview
7.1.1.1 Brazil
7.1.1.2 Argentina
7.1.1.3 Rest of South America
7.2 South America Monoclonal Antibodies in Veterinary Health Market Outlook (2017-2032)
7.2.1 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2017-2023)
7.2.2 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2024-2032)
7.3 South America Monoclonal Antibodies in Veterinary Health Market by Region
7.3.1 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
7.3.2 South America Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
7.4 South America Monoclonal Antibodies in Veterinary Health Market by Product Type
7.4.1 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
7.4.2 South America Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Product Type, 2023–2032
7.4.3 South America Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
7.5 South America Monoclonal Antibodies in Veterinary Health Market by Animal Type
7.5.1 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2032)
7.5.2 South America Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Animal Type, 2023–2032
7.6 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Region
7.6.1 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
7.6.2 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
7.7 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Product Type
7.7.1 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
7.7.2 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
7.8 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Animal Type
7.8.1 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2023)
7.8.2 South America Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2024-2032)
7.9 South America Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate Comparison 2018–2032
7.9.1 South America Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Region
7.9.2 South America Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Product Type
7.9.3 South America Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Animal Type
7.1 South America Monoclonal Antibodies in Veterinary Health Market Share Comparison 2017–2032
7.10.1 South America Monoclonal Antibodies in Veterinary Health Market Share by Region
7.10.2 South America Monoclonal Antibodies in Veterinary Health Market Share by Product Type
7.10.3 South America Monoclonal Antibodies in Veterinary Health Market Share by Animal Type
Chapter 8 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Overview
8.1 Middle East and Africa Market Snapshot
8.1.1 Regional Overview
8.1.1.1 GCC
8.1.1.2 South Africa
8.1.1.3 Israel
8.1.1.4 Rest of Middle East and Africa
8.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Outlook (2017-2032)
8.2.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2017-2023)
8.2.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) (2024-2032)
8.3 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market by Region
8.3.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2032)
8.3.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
8.4 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market by Product Type
8.4.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2032)
8.4.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Product Type, 2023–2032
8.4.3 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Region, 2023–2032
8.5 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market by Animal Type
8.5.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2032)
8.5.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Attractiveness Analysis by Animal Type, 2023–2032
8.6 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Region
8.6.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2017-2023)
8.6.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Region (2024-2032)
8.7 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Product Type
8.7.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2017-2023)
8.7.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2024-2032)
8.8 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) by Animal Type
8.8.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2017-2023)
8.8.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Value (US$ Mn) and Volume (Units) Comparison by Animal Type (2024-2032)
8.9 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate Comparison 2018–2032
8.9.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Region
8.9.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Product Type
8.9.3 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Y-o-Y Growth Rate by Animal Type
8.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Share Comparison 2017–2032
8.10.1 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Share by Region
8.10.2 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Share by Product Type
8.10.3 Middle East and Africa Monoclonal Antibodies in Veterinary Health Market Share by Animal Type
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
